NCT00405392View on ClinicalTrials.gov

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

PHASE4CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

March 22, 2007

Primary Completion Date

May 27, 2008

Study Completion Date

May 27, 2008

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Ibandronate (SB743830HD)

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY